BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 17173679)

  • 1. Adherence to cardioprotective medications and mortality among patients with diabetes and ischemic heart disease.
    Ho PM; Magid DJ; Masoudi FA; McClure DL; Rumsfeld JS
    BMC Cardiovasc Disord; 2006 Dec; 6():48. PubMed ID: 17173679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease.
    Ho PM; Magid DJ; Shetterly SM; Olson KL; Maddox TM; Peterson PN; Masoudi FA; Rumsfeld JS
    Am Heart J; 2008 Apr; 155(4):772-9. PubMed ID: 18371492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence Tradeoff to Multiple Preventive Therapies and All-Cause Mortality After Acute Myocardial Infarction.
    Korhonen MJ; Robinson JG; Annis IE; Hickson RP; Bell JS; Hartikainen J; Fang G
    J Am Coll Cardiol; 2017 Sep; 70(13):1543-1554. PubMed ID: 28935030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and correlates of cardiovascular medication use among nursing home residents with ischemic heart disease: results from the SHELTER study.
    Foebel AD; Liperoti R; Gambassi G; Gindin J; Ben Israel J; Bernabei R; Onder G
    J Am Med Dir Assoc; 2014 Jun; 15(6):410-5. PubMed ID: 24559641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Persistent Medication Adherence and Compliance with Lifestyle Recommendations on Major Cardiovascular Events and One-Year Mortality in Patients with Type 2 Diabetes and Advanced Stages of Atherosclerosis: Results From a Prospective Cohort Study.
    Shalaeva EV; Bano A; Kasimov U; Janabaev B; Laimer M; Saner H
    Glob Heart; 2023; 18(1):61. PubMed ID: 37928361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive Medication Management and Medication Adherence for Chronic Conditions.
    Brummel A; Carlson AM
    J Manag Care Spec Pharm; 2016 Jan; 22(1):56-62. PubMed ID: 27015052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in adherence to secondary prevention medications in elderly post-myocardial infarction patients.
    Choudhry NK; Setoguchi S; Levin R; Winkelmayer WC; Shrank WH
    Pharmacoepidemiol Drug Saf; 2008 Dec; 17(12):1189-96. PubMed ID: 18956426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Diabetes Mellitus Status and Glycemic Control With Secondary Prevention Medication Adherence After Acute Myocardial Infarction.
    Adamek KE; Ramadurai D; Gunzburger E; Plomondon ME; Ho PM; Raghavan S
    J Am Heart Assoc; 2019 Feb; 8(3):e011448. PubMed ID: 30712488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to statins, beta-blockers and angiotensin-converting enzyme inhibitors following a first cardiovascular event: a retrospective cohort study.
    Blackburn DF; Dobson RT; Blackburn JL; Wilson TW; Stang MR; Semchuk WM
    Can J Cardiol; 2005 May; 21(6):485-8. PubMed ID: 15917876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular Medication Use and Long-Term Outcomes of First Nations and Non-First Nations Patients Following Diagnostic Angiography: A Retrospective Cohort Study.
    Dahl L; Schultz A; McGibbon E; Brownlie J; Cook C; Elbarouni B; Katz A; Nguyen T; Sawatzky JA; Sinclaire M; Throndson K; Prior HJ; Fransoo R
    J Am Heart Assoc; 2019 Aug; 8(16):e012040. PubMed ID: 31405352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying adherent patients to newly initiated statins using previous adherence to chronic medications.
    Majd Z; Mohan A; Paranjpe R; Abughosh SM
    J Manag Care Spec Pharm; 2021 Feb; 27(2):186-197. PubMed ID: 33506725
    [No Abstract]   [Full Text] [Related]  

  • 12. Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy.
    Corrao G; Conti V; Merlino L; Catapano AL; Mancia G
    Clin Ther; 2010 Feb; 32(2):300-10. PubMed ID: 20206788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Changes in Medication Use and Adherence With Accountable Care Organization Exposure in Patients With Cardiovascular Disease or Diabetes.
    McWilliams JM; Najafzadeh M; Shrank WH; Polinski JM
    JAMA Cardiol; 2017 Sep; 2(9):1019-1023. PubMed ID: 28700790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients undergoing infrainguinal bypass to treat atherosclerotic vascular disease are underprescribed cardioprotective medications: effect on graft patency, limb salvage, and mortality.
    Henke PK; Blackburn S; Proctor MC; Stevens J; Mukherjee D; Rajagopalin S; Upchurch GR; Stanley JC; Eagle KA
    J Vasc Surg; 2004 Feb; 39(2):357-65. PubMed ID: 14743136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization of Evidence-Based Secondary Prevention Medications at the Time of Discharge in Patients with Acute Coronary Syndrome (ACS) in Qatar.
    El-Hajj MS; Saad A; Al-Suwaidi J; Al-Marridi WZ; Elkhalifa DH; Mohamed AA; Mahfoud ZR
    Curr Vasc Pharmacol; 2016; 14(4):394-403. PubMed ID: 26916397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensity of Guideline-Directed Medical Therapy for Coronary Heart Disease and Ischemic Heart Failure Outcomes.
    Crosier R; Austin PC; Ko DT; Lawler PR; Stukel TA; Farkouh ME; Wang X; Spertus JA; Ross HJ; Lee DS
    Am J Med; 2021 May; 134(5):672-681.e4. PubMed ID: 33181105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Adherence to Renin-Angiotensin System Inhibitors and β-Blockers After Heart Failure Hospitalization in Senior Patients.
    Qin X; Hung J; Teng TK; Briffa T; Sanfilippo FM
    J Cardiovasc Pharmacol Ther; 2020 Nov; 25(6):531-540. PubMed ID: 32500739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term medication adherence after myocardial infarction: experience of a community.
    Shah ND; Dunlay SM; Ting HH; Montori VM; Thomas RJ; Wagie AE; Roger VL
    Am J Med; 2009 Oct; 122(10):961.e7-13. PubMed ID: 19560749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing prescribing of guideline-recommended medications for ischaemic heart diseases: a systematic review and meta-analysis of interventions targeted at healthcare professionals.
    Nguyen T; Nguyen HQ; Widyakusuma NN; Nguyen TH; Pham TT; Taxis K
    BMJ Open; 2018 Jan; 8(1):e018271. PubMed ID: 29326185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does age modify the relationship between adherence to secondary prevention medications and mortality after acute myocardial infarction? A nested case-control study.
    Lenzi J; Rucci P; Castaldini I; Protonotari A; Di Pasquale G; Di Martino M; Perrone E; Forti P; Fantini MP
    Eur J Clin Pharmacol; 2015 Feb; 71(2):243-50. PubMed ID: 25529226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.